IUHSA
PEAR

Itau Unibanco Holding S.A.’s Pear Therapeutics, Inc. Class A Common Stock PEAR Stock Holding History

Itau Unibanco Holding S.A.’s Portfolio PEAR Stock Details PEAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-4,443
Closed -$9K – 664
2022
Q3 		$9K Buy
+4,443
New +$7.54K ﹤0.01% 496

Other funds holding PEAR

Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
5VM
5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return
SGA
SB Global Advisers London, United Kingdom $861M AUM 71.72% 1-Year Est. Return
AV
Arboretum Ventures Ann Arbor, Michigan $1.72M AUM 82.7% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
TAA
TB Alternative Assets Grand Cayman, Cayman Islands $623M AUM 154.99% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PT
Palantir Technologies Denver, Colorado $9.72M AUM 6.46% 1-Year Est. Return

Itau Unibanco Holding S.A.'s PEAR Position: Q4 2022 in Review

Itau Unibanco Holding S.A. sold out of Pear Therapeutics, Inc. Class A Common Stock (PEAR) in Q4 2022, closing a stake of 4,443 shares — an estimated $9K sold.

Itau Unibanco Holding S.A. first reported a position in PEAR in Q3 2022 and held it in 1 quarter. The position peaked at $9K in Q3 2022. 64 funds tracked by Wall St. Rank hold PEAR as of Q4 2022.

  • Itau Unibanco Holding S.A. reported no remaining Pear Therapeutics, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
  • Itau Unibanco Holding S.A. sold 4,443 Pear Therapeutics, Inc. Class A Common Stock shares in Q4 2022, an estimated $9K.
  • Itau Unibanco Holding S.A. first reported a position in Pear Therapeutics, Inc. Class A Common Stock in Q3 2022 and held it in 1 quarter.
  • Itau Unibanco Holding S.A.'s Pear Therapeutics, Inc. Class A Common Stock position peaked at $9K in Q3 2022.
  • 64 funds tracked by Wall St. Rank held Pear Therapeutics, Inc. Class A Common Stock as of Q4 2022.

Based on Itau Unibanco Holding S.A.'s 13F filing for Q4 2022, filed 9 Feb 2023.